Skip to main content

HRB National Drugs Library

Home > EMCDDA–Europol Joint Report on a new psychoactive substance: methyl 2-{[1-(5-fluoropentyl)-1H-indazole-3-carbonyl]amino}-3,3-dimethylbutanoate (5F-MDMB-PINACA; 5F-ADB).

European Monitoring Centre for Drugs and Drug Addiction. (2017) EMCDDA–Europol Joint Report on a new psychoactive substance: methyl 2-{[1-(5-fluoropentyl)-1H-indazole-3-carbonyl]amino}-3,3-dimethylbutanoate (5F-MDMB-PINACA; 5F-ADB). Luxembourg: Joint Reports, Publications Office of the European Union.

[img]
Preview
 PDF (EMCDDA–Europol Joint Report on a new psychoactive substance) - Published Version
667kB

In March 2017, the EMCDDA and Europol examined the available information on the new psychoactive substance methyl 2-{[1-(5-fluoropentyl)-1H-indazole-3-carbonyl]amino}- 3,3-dimethylbutanoate, commonly known as 5F-MDMB-PINACA, through a joint assessment. The two organisations launched a data collection on this substance for the preparation of a Joint Report as stipulated by Article 5.1 of the Council Decision. The Joint Report was submitted to the Council, the Commission and the European Medicines Agency on 3 July 2017.

Item Type
Report
Publication Type
International, Report
Drug Type
New psychoactive substance
Intervention Type
Harm reduction, Screening / Assessment
Date
September 2017
Pages
16 p.
Publisher
Joint Reports, Publications Office of the European Union
Corporate Creators
European Monitoring Centre for Drugs and Drug Addiction
Place of Publication
Luxembourg
EndNote
View
Accession Number
HRB (Electronic Only)
Subjects
B Substances > New (novel) psychoactive substances
VA Geographic area > Europe

Repository Staff Only: item control page